Highlights Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Delayed NSE India S.E. Other stock markets 09:15:05 07/06/2024 am IST			5-day change	1st Jan Change
148.6 ^INR	+0.30%		+1.65%	+6.66%

14/05	Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy	MT
13/05	Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024	10/05	CI
Piramal Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	10/05	CI
Piramal Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	10/05	CI
Piramal Pharma Gets US FDA's Establishment Inspection Report for Riverview, US Facility	18/04	MT
Piramal Pharma Forays into Men Grooming Products	10/04	MT
Piramal Pharma Limited Announces the Launch of BOHEM Product Range	10/04	CI
Piramal Pharma Turns to Profit in Fiscal Q3	31/01	MT
Piramal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	30/01	CI
Piramal Pharma Solutions Commences Opening of Its Antibody-Drug Conjugate Manufacturing Expansion in Grangemouth, Scotland	18/12	CI
Piramal Pharma Gets US FDA's EIR Report After Bethlehem, USA Unit Inspection	09/11	MT
Piramal Pharma Swings to Profit in Fiscal Q2	30/23/30	MT
Piramal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	27/23/27	CI
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities At Ahmedabad Discovery Services Site	16/23/16	CI
Piramal Pharma Gets Two Observations from US FDA After Inspection of US Facility	29/23/29	MT
Piramal Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	03/23/03	CI
Piramal Pharma Gets SEBI Nod for INR10.50 Billion Rights Issue	19/23/19	MT
Canada's CDPQ Sells Stake in Piramal Pharma	19/23/19	MT
Piramal Pharma's Consolidated Profit Slumps in Fiscal Q4	26/23/26	MT
Piramal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	24/23/24	CI
US FDA Concludes Inspection at Piramal Pharma's Sellersville Manufacturing Unit	19/23/19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Highlights

Filters